Elekta receives orders for Leksell Gamma Knife® valued at SEK 155 million

Elekta receives orders for Leksell Gamma Knife® valued at SEK 155 million Elekta has signed agreements to deliver Leksell Gamma Knife® equipment to Europe, the U.S., Japan, Asia and Mexico. The agreements include delivery of Leksell Gamma Knife® equipment and reloads of existing installations. The total order value is approximately SEK 155 M. Most of the deliveries are planned for fiscal year 2001/2002. "It is with great pleasure I can announce that Elekta's Leksell Gamma Knife® order bookings for the second quarter, August-October 2001, continued to be strong in all our markets", says Tomas Puusepp, responsible for Elekta's neurosurgery business. "I am very pleased to see continued growth and interest in Gamma Knife® Surgery world-wide and how well the new generation Leksell Gamma Knife® C has been received. Elekta continues to offer a major alternative to open surgery by providing non-invasive radiosurgery for neurological disorders", ends Tomas Puusepp. At the end of September 2001, a total of 158 Leksell Gamma Knife® units were installed worldwide. Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective and cost efficient and gentle to the patient. For further information, please contact: Lars Jonsteg, VP Corporate Relations, Elekta AB (publ), tel. +46 8 587 254 82 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2001/11/13/20040524BIT20920/wkr0006.pdf

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com


Documents & Links